Cetuximab in first-line treatment of metastatic colorectal cancer in a real-life setting: Preliminary results of the EREBUS cohort.

被引：0
|
作者：
Smith, Denis
Rouyer, Magali
Mitry, Emmanuel
Monnereau, Alain
Cunha, Antonio Sa
Bignon, Emmanuelle
Le Monies, Alise
Jove, Jeremy
Noize, P.
Moore, Nicholas
Fourrier-Reglat, Annie
机构：
[1] Univ Hosp, Med Oncol, Bordeaux, France
[2] Univ V Segalen, Serv Pharmacol, Bordeaux, France
[3] Inst Curie, St Cloud, France
[4] Inst Bergonie, Bordeaux, France
[5] Chirurg Digest Hop Haut Leveque, Pessac, France
[6] Univ Bordeaux, Serv Pharmacol, Bordeaux, France
[7] Serv Pharmacol, Bordeaux, France
[8] Univ Victor Segalen, Bordeaux, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 04期
关键词：
D O I：
10.1200/jco.2012.30.4_suppl.621
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
621
引用
收藏
页数：2
相关论文
共 50 条
  • [21] First-line targeted therapies in the treatment of metastatic colorectal cancer - role of cetuximab
    Tonini, Giuseppe
    Calvieri, Alice
    Vincenzi, Bruno
    Santini, Daniele
    ONCOTARGETS AND THERAPY, 2009, 2 : 73 - 82
  • [22] Secondary Metastases Resection After Bevacizumab Plus Irinotecan-Based Chemotherapy in First-Line Therapy of Metastatic Colorectal Cancer in a Real-Life Setting: Results of the ETNA Cohort
    Magali Rouyer
    Denis Smith
    Christophe Laurent
    Yves Becouarn
    Rosine Guimbaud
    Pierre Michel
    Nicole Tubiana-Mathieu
    Aurélie Balestra
    Jérémy Jové
    Philip Robinson
    Pernelle Noize
    Nicholas Moore
    Alain Ravaud
    Annie Fourrier-Réglat
    Targeted Oncology, 2016, 11 : 83 - 92
  • [23] Secondary Metastases Resection After Bevacizumab Plus Irinotecan-Based Chemotherapy in First-Line Therapy of Metastatic Colorectal Cancer in a Real-Life Setting: Results of the ETNA Cohort
    Rouyer, Magali
    Smith, Denis
    Laurent, Christophe
    Becouarn, Yves
    Guimbaud, Rosine
    Michel, Pierre
    Tubiana-Mathieu, Nicole
    Balestra, Aurelie
    Jove, Jeremy
    Robinson, Philip
    Noize, Pernelle
    Moore, Nicholas
    Ravaud, Alain
    Fourrier-Reglat, Annie
    TARGETED ONCOLOGY, 2016, 11 (01) : 83 - 92
  • [24] Surgical resection of metastases and survival outcomes in patients with metastatic colorectal cancer (mCRC) treated with cetuximab (CTX) in the EREBUS cohort of real-life use
    Smith, D.
    Cunha, A. Sa
    Rouyer, M.
    Noize, P.
    Jove, J.
    Bignon, E.
    Monnereau, A.
    Francois, E.
    Mitry, E.
    Fourrier-Reglat, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S538 - S538
  • [25] Cetuximab in first line treatment of metastatic colorectal cancer
    Barone, Carlo
    Belisari, Andrea
    Ciardiello, Fortunato
    D'Angiolella, Lucia
    Furneri, Gianluca
    Mantovani, Lorenzo
    Normanno, Nicola
    Piacentini, Patrizio
    Pinto, Carmine
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2012, 13 : 3 - 78
  • [26] Effectiveness of first-line cetuximab in wild-typeRASmetastatic colorectal cancer according to tumourBRAFmutation status from the EREBUS cohort
    Rouyer, Magali
    Francois, Eric
    Sa Cunha, Antonio
    Monnereau, Alain
    Bignon, Emmanuelle
    Jove, Jeremy
    Lassalle, Regis
    Droz-Perroteau, Cecile
    Moore, Nicholas
    Noize, Pernelle
    Fourrier-Reglat, Annie
    Smith, Denis
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (03) : 1120 - 1128
  • [27] Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer
    Bokemeyer, Carsten
    Bondarenko, Igor
    Makhson, Anatoly
    Hartmann, Joerg T.
    Aparicio, Jorge
    de Braud, Filippo
    Donea, Serban
    Ludwig, Heinz
    Schuch, Gunter
    Stroh, Christopher
    Loos, Anja H.
    Zubel, Angela
    Koralewski, Piotr
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) : 663 - 671
  • [28] The Efficacy and Safety of Treatment Regimens Used in the First-Line Setting in Metastatic Pancreatic Cancer Patients A Multicenter Real-Life Study
    Akdeniz, Nadiye
    Kaplan, Muhammet Ali
    Inanc, Mevlude
    Uncu, Dogan
    Ergun, Yakup
    Kucukoner, Mehmet
    Demirci, Ayse
    Sendur, Mehmet Ali Nahit
    Besiroglu, Mehmet
    Topcu, Atakan
    Yerlikaya, Halis
    Urakci, Zuhat
    Kilickap, Saadettin
    Isikdogan, Abdurrahman
    PANCREAS, 2022, 51 (09) : 1153 - 1159
  • [29] Cetuximab as first-line treatment for metastatic colorectal cancer (mCRC): a model-based economic evaluation in Indonesia setting
    Putri, Septiara
    Saldi, Siti Rizny F.
    Khoe, Levina Chandra
    Setiawan, Ery
    Megraini, Amila
    Santatiwongchai, Benjarin
    Nugraha, Ryan R. R.
    Permanasari, Vetty Y. Y.
    Nadjib, Mardiati
    Sastroasmoro, Sudigdo
    Armansyah, Armansyah
    BMC CANCER, 2023, 23 (01)
  • [30] Cetuximab as first-line treatment for metastatic colorectal cancer (mCRC): a model-based economic evaluation in Indonesia setting
    Septiara Putri
    Siti Rizny F. Saldi
    Levina Chandra Khoe
    Ery Setiawan
    Amila Megraini
    Benjarin Santatiwongchai
    Ryan R. Nugraha
    Vetty Y. Permanasari
    Mardiati Nadjib
    Sudigdo Sastroasmoro
    Armansyah Armansyah
    BMC Cancer, 23 (1)
12345